Release Date: 25/02/14 18:13 Summary: 4D and Interim Financial Report Price Sensitive: Yes Download Document 921.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%